Advanced biosensors for virus detection - smart diagnostics to combat sars-cov-2 1st ed. 2022 editio

Page 1


AdvancedBiosensorsforVirusDetection-Smart DiagnosticstoCombatSARS-CoV-21sted.2022 Edition

https://ebookmass.com/product/advanced-biosensors-for-virusdetection-smart-diagnostics-to-combat-sars-cov-2-1sted-2022-edition-edited-by-raju-khan/

Instant digital products (PDF, ePub, MOBI) ready for you

Download now and discover formats that fit your needs...

Application of Natural

Products

in SARS-CoV-2 Kamal Niaz

https://ebookmass.com/product/application-of-natural-products-in-sarscov-2-kamal-niaz/

ebookmass.com

Advanced Biosensors for Health Care Applications Inamuddin

https://ebookmass.com/product/advanced-biosensors-for-health-careapplications-inamuddin/

ebookmass.com

From SARS to COVID-19_ A previously unknown SARS- related coronavirus (SARS-CoV-2) of pandemic potential infecting humans – Call for a One Health approach Mohamed E. El Zowalaty

https://ebookmass.com/product/from-sars-to-covid-19_-a-previouslyunknown-sars-related-coronavirus-sars-cov-2-of-pandemic-potentialinfecting-humans-call-for-a-one-health-approach-mohamed-e-el-zowalaty/ ebookmass.com

Antarctica: What Everyone Needs to Know® David Day

https://ebookmass.com/product/antarctica-what-everyone-needs-to-knowdavid-day/

ebookmass.com

Ashoka: Portrait of a Philosopher King Olivelle

https://ebookmass.com/product/ashoka-portrait-of-a-philosopher-kingolivelle/

ebookmass.com

Twelve of Roses: An Anti-love Story (Bitter & Sick Book 1)

https://ebookmass.com/product/twelve-of-roses-an-anti-love-storybitter-sick-book-1-natalie-bennett/

ebookmass.com

SAP S/4HANA Financial Accounting Configuration: Learn Configuration and Development on an S/4 System, 2nd Edition Andrew Okungbowa

https://ebookmass.com/product/sap-s-4hana-financial-accountingconfiguration-learn-configuration-and-development-onan-s-4-system-2nd-edition-andrew-okungbowa-2/ ebookmass.com

Shaw's

Textbook of Gynaecology 17th Revised edition Edition V. G. Padubidri

https://ebookmass.com/product/shaws-textbook-of-gynaecology-17threvised-edition-edition-v-g-padubidri/

ebookmass.com

Policy

Capacity and Governance: Assessing Governmental Competences and Capabilities in Theory and Practice 1st Edition Xun Wu

https://ebookmass.com/product/policy-capacity-and-governanceassessing-governmental-competences-and-capabilities-in-theory-andpractice-1st-edition-xun-wu/

ebookmass.com

A Treasury of Success Unlimited (An Official Publication of the Napoleon Hill Foundation) Og Mandino (Editor)

https://ebookmass.com/product/a-treasury-of-success-unlimited-anofficial-publication-of-the-napoleon-hill-foundation-og-mandinoeditor/

ebookmass.com

AdvancedBiosensorsfor VirusDetection

AdvancedBiosensorsfor VirusDetection

CSIR-AdvancedMaterials& ProcessesResearchInstitute(AMPRI),Bhopal,India

ArpanaParihar

CSIR-AdvancedMaterials& ProcessesResearchInstitute(AMPRI),Bhopal,India

AjeetKaushik

AssistantProfessorofChemistry,NanoBioTechLaboratory,Departmentof EnvironmentalEngineering,FloridaPolytechnicUniversity,Lakeland, FL,UnitedStates

AshokKumar DepartmentofBiochemistry,AllIndiaInstituteofMedicalSciences(AIIMS), Bhopal,India

AcademicPressisanimprintofElsevier 125LondonWall,LondonEC2Y5AS,UnitedKingdom 525BStreet,Suite1650,SanDiego,CA92101,UnitedStates 50HampshireStreet,5thFloor,Cambridge,MA02139,UnitedStates TheBoulevard,LangfordLane,Kidlington,OxfordOX51GB,UnitedKingdom

Copyright©2022ElsevierInc.Allrightsreserved.

Nopartofthispublicationmaybereproducedortransmittedinanyformorbyanymeans,electronicor mechanical,includingphotocopying,recording,oranyinformationstorageandretrievalsystem,withoutpermission inwritingfromthepublisher.Detailsonhowtoseekpermission,furtherinformationaboutthePublisher’ s permissionspoliciesandourarrangementswithorganizationssuchastheCopyrightClearanceCenterandthe CopyrightLicensingAgency,canbefoundatourwebsite: www.elsevier.com/permissions

ThisbookandtheindividualcontributionscontainedinitareprotectedundercopyrightbythePublisher(otherthan asmaybenotedherein).

Notices

Knowledgeandbestpracticeinthisfieldareconstantlychanging.Asnewresearchandexperiencebroadenour understanding,changesinresearchmethods,professionalpractices,ormedicaltreatmentmaybecomenecessary.

Practitionersandresearchersmustalwaysrelyontheirownexperienceandknowledgeinevaluatingandusingany information,methods,compounds,orexperimentsdescribedherein.Inusingsuchinformationormethodsthey shouldbemindfuloftheirownsafetyandthesafetyofothers,includingpartiesforwhomtheyhaveaprofessional responsibility.

Tothefullestextentofthelaw,neitherthePublishernortheauthors,contributors,oreditors,assumeanyliability foranyinjuryand/ordamagetopersonsorpropertyasamatterofproductsliability,negligenceorotherwise,or fromanyuseoroperationofanymethods,products,instructions,orideascontainedinthematerialherein.

ISBN:978-0-12-824494-4

ForInformationonallAcademicPresspublications visitourwebsiteat https://www.elsevier.com/books-and-journals

Publisher: StacyMasucci

AcquisitionsEditor: KattieWashington

EditorialProjectManager: TracyI.Tufaga

ProductionProjectManager: NiranjanBhaskaran

CoverDesigner: VictoriaPearson

TypesetbyMPSLimited,Chennai,India

CHAPTER1Theemergenceofsevereacuterespiratory syndrome-coronavirus2epidemicandpandemic .............................. 1 TabassumZafar

1.1 Introduction................................................................................................................1

1.2 Severeacuterespiratorysyndrome-coronavirus2:thememberofthe coronavirusfamily......................................................................................................1

1.2.1SARS-CoV-2inconnectionwithsevereacuterespiratorysyndromecoronavirusandMiddleEastrespiratorysyndrome-coronavirus...................2

1.3 Virionstructureofsevereacuterespiratorysyndrome-coronavirus2......................3

1.4 Pathophysiologyofsevereacuterespiratorysyndrome-coronavirus2 infection......................................................................................................................

1.5 Transmissibilityofsevereacuterespiratorysyndrome-coronavirus2.....................7

1.6 Originandetiologyofsevereacuterespiratorysyndrome-coronavirus2................8

1.7 Fromepidemictopandemic....................................................................................10

2.1

2.6

3.3

3.5 Pathogenesisofcoronavirus19...............................................................................46

3.5.1Infectionandviremia.....................................................................................47

3.5.2Inflammationandcytokinestorm..................................................................48

3.5.3Postinflammatorypulmonaryfibrosis...........................................................52

3.6 Extrapulmonarymanifestationsofcoronavirus19..................................................53

3.6.1Cardiacinvolvement......................................................................................53

3.6.2Hematologicalmanifestations........................................................................53

3.6.3Renalmanifestation.......................................................................................54

3.6.4GastrointestinalandHepatobiliarymanifestations........................................54

3.6.5Endocrinemanifestations...............................................................................54

3.6.6Neurologicalmanifestations..........................................................................54 3.7

4.2

4.3 qRT-PCRfordetectionofSARS-CoV-2RNA.......................................................64

4.4 Cartridge-basednucleicacidamplificationtests.....................................................67

4.5 Poolingofspecimensfornucleicacidamplificationtest.......................................67

4.6 Isothermalassays......................................................................................................68

4.7 Rapidantigendetectiontest.....................................................................................69

4.8 QualitycontrolofCOVID-19testing......................................................................70

4.9

5.1 Introduction..............................................................................................................79

5.2 Pathophysiologyofcoronavirusdisease..................................................................79

5.2.1Stageofinfectionandviremia......................................................................80

5.2.2Stageofinflammationandcytokinestorm...................................................80

5.2.3Postinflammatorypulmonaryfibrosisanditscomplications........................80

5.3 Therapeuticsofprovenutility,targetingstageofinfectionandviremia...............81

5.3.1Monoclonalantibodies...................................................................................81

5.4 Therapeuticsoflimitedorunprovenutility,targetingstageof Infectionandviremia...............................................................................................82

5.4.1Remdesivir.....................................................................................................82

5.4.2Hydroxychloroquine.......................................................................................83

5.4.3Ivermectin......................................................................................................84

5.4.4Lopinavir........................................................................................................84

5.5 Therapeuticsofprovenutility,targetingcytokinestorm........................................85

5.5.1Glucocorticoids..............................................................................................85

5.5.2Anticoagulants................................................................................................86

5.6 Therapeuticsoflimitedutility,targetingcytokinestorm........................................86

5.6.1Tocilizumab....................................................................................................86

5.6.2Interferons......................................................................................................86

5.6.3Baricitinib.......................................................................................................87

5.6.4Bevacizumab..................................................................................................87

5.6.5Infliximab.......................................................................................................87

5.6.6Artesunate.......................................................................................................87

5.7 Therapeuticsoflimitedoruncertainutility,targetingpost-coronavirus diseasecomplications...............................................................................................88

5.7.1Drugstargetingpulmonaryfibrosis:nintedanibandpirfenidone.................88

5.7.2Colchicine......................................................................................................88

5.7.3Drugstargetingpulmonaryhypertension......................................................88

5.7.4Longtermanticoagulationtherapy................................................................89

5.8 Conclusion................................................................................................................89 References.................................................................................................................90

CHAPTER6Genomic,proteomicbiomarkersandriskfactorsassociated withCOVID-19 95 HimadriSingh,RajeevNemaandAshokKumar

6.1 Introduction..............................................................................................................95

6.2 Biomarkers...............................................................................................................96

6.3 ProteomicBiomarkersforCOVID-19.....................................................................96

6.3.1Cytokines........................................................................................................96

6.3.2Acute-phaseproteins......................................................................................97

6.3.3Clinicalbiochemicalparameters...................................................................99

6.3.4IdentificationofnovelproteomicsbiomarkersforCOVID-19....................99

6.4 Geneticbiomarkers................................................................................................102

6.4.1Geneticpredispositionbiomarkers..............................................................102

6.4.2NoncodingRNA..........................................................................................105

6.5 Conclusionandfutureperspective.........................................................................106 References...............................................................................................................106

CHAPTER7Biological/syntheticreceptors(antibody,enzyme,andaptamer) usedforbiosensorsdevelopmentforvirusdetection ..................... 113 AkankshaRoberts,SubhasisMahariandSonuGandhi

7.1 Introduction............................................................................................................113

7.2 Typesofbioreceptors.............................................................................................114

7.2.1Enzymes.......................................................................................................114

7.2.2Antibodyandantigen...................................................................................115

7.2.3Nucleicacid.................................................................................................115

7.2.4Wholecell....................................................................................................115

7.2.5Aptamers......................................................................................................115

7.2.6Peptides........................................................................................................116

7.2.7Molecularlyimprintedpolymers.................................................................116

7.2.8Othersensorparadigms...............................................................................116

7.3 Propertiesofbiosensorsbasedonbioreceptors.....................................................116

7.4 Examplesofbiosensorsfordetectionofcoronavirusdisease2019basedon differentbioreceptors.............................................................................................117

7.4.1Antibodyreceptorbased..............................................................................117

7.4.2Antigenreceptorbased................................................................................118

7.4.3Nucleicacidreceptorbased.........................................................................121

7.5

CHAPTER8Potentialelectrochemicalbiosensorsforearlydetectionof viralinfection ....................................................................................

8.1 Introduction............................................................................................................133

8.2 Typesofviralinfectionsandtheirdetection.........................................................136

8.2.1Respiratoryviralinfection...........................................................................136

CHAPTER9OpticalbiosensorsforSARS-CoV-2detection

9.1 Introduction............................................................................................................155

9.2 Biosensors:anintroductiontoopticalbiosensors.................................................156

9.3 Surface-plasmonresonance-basedbiosensors.......................................................157

9.4 Localizedsurfaceplasmonresonance-basedopticalbiosensors...........................158

9.5 Surface-enhancedRamanscattering-basedopticalbiosensors.............................161

9.6 OpticallateralflowassayforSARS-CoV-2-detection.........................................161

9.7 Challengesindevelopingopticalbiosensors.........................................................163

9.8 Conclusionandfutureperspectives.......................................................................163

RupeshK.Mishra,NavinPai,K.YugenderGoud,RaviRanjanKumarNiraj, DeepakKumar,GaurangPatel,VinodSinghGour,AminZareei, RahimRahimi,VinaySharma,RogerNarayanandLiaStanciu

10.1 Introduction............................................................................................................167

10.2 Nucleicacid-baseddetection.................................................................................168 10.2.1RT-qPCR-baseddetection........................................................................168

10.3 Serologicaltesting..................................................................................................169

10.4 BiosensorsforCOVID-19diagnostics..................................................................170

10.4.1ElectrochemicalbiosensorsforSARS-CoV-2detection..........................171

10.4.2Opticalbiosensors......................................................................................173

10.4.3CRISPR-basedbiosensorforSARS-CoV-2..............................................175

10.5 Electricalandpiezoelectricbiosensors..................................................................176

10.5.1COVIDtestbasedonantibodydetection..................................................177

10.5.2Detectionofblockingantibodies...............................................................178

10.5.3HarnessingwearabledevicestodetectSARS-CoV-2infections.............179

10.5.4Smarttoilettechnology..............................................................................179

10.6 Futuredirections.....................................................................................................179

10.7 Conclusions............................................................................................................181

CHAPTER11Roleofmagneticnanoparticlesindevelopmentofbiosensors

12.6 Conclusionandfutureperspective.........................................................................213

CHAPTER13Multiplexedbiosensorsforvirusdetection

13.1

MintuPal,VishalDas,H.P.DekaBoruahandC.Chikkaputtaiah

13.2 Biosensors...............................................................................................................220

13.3 Applicationofmultiplexbiosensorsondetectionofviruses................................221

CHAPTER14Electricalbiosensorsforvirusdetection.........................................

GautamBacher,SunilBhandandShreyasDeshpande 14.1

14.8

CHAPTER15Diagnosticbiosensorsforcoronavirusesandrecent developments .................................................................................... 261 ShimaaEissa

15.1 Introduction............................................................................................................261

15.2 Traditionaldetectionmethods................................................................................262

15.3 Biosensorsincoronavirusdetection......................................................................263

15.3.1Electrochemicalbiosensors........................................................................264

15.3.2Opticalbiosensors......................................................................................270

15.3.3Field-effecttransistor.................................................................................273

15.4 Conclusionsandfutureperspectives......................................................................273 References...............................................................................................................274

CHAPTER16Fluorescence-basedbiosensorsforSARS-CoV-2viral infectiondiagnostics ........................................................................ 279 JoshyJosephandBinduRameshan

16.1 Introduction............................................................................................................279

16.2 Fluorescence-basedstrategiesinbiosensors..........................................................280

16.2.1DNAstainingandfluorescencelabeling...................................................280

16.2.2Fo ¨ rsterresonanceenergytransfer-basedbiosensors................................281

16.2.3Metal-enhancedfluorescence-basedbiosensors........................................282

16.3 Fluorescence-basedbiosensorsinviraldiagnosticapplications...........................282

16.3.1Hybridization-basedprobes.......................................................................283

16.3.2Light-upRNAaptamerprobes..................................................................285

16.3.3Antibody-basedprobes..............................................................................287

16.4 Advancesinfluorescence-basedbiosensorsforSARS-CoV-2viral infectiondiagnostics...............................................................................................288

16.4.1Nucleicaciddetection................................................................................288

16.4.2Proteindetection........................................................................................291

16.4.3Otherapproaches........................................................................................295

16.5 Conclusion..............................................................................................................296 References...............................................................................................................296

CHAPTER17Miniaturizedanalyticalsystemforpoint-of-carecoronavirus infectiondiagnostics ........................................................................ 305 PushpeshRanjan,Mohd.AbubakarSadique,ShaluYadav, ArpanaPariharandRajuKhan

17.1 Introduction............................................................................................................305

17.2 Currentdiagnostictechniques................................................................................307

17.2.1Polymerasechainreaction/reversetranscription-polymerasechain reaction.......................................................................................................307

17.2.2Loop-mediatedisothermalamplification/reversetranscriptionand loop-mediatedisothermalamplification....................................................309

17.2.3Clusteredregularlyinterspacedshortpalindromicrepeats.......................310

17.2.4Computerizedtomographyscan................................................................311

17.2.5Electrochemical-basedbiosensor...............................................................312

17.2.6Optical-basedbiosensor.............................................................................314

17.2.7Lateralflowimmunoassay.........................................................................316

17.2.8Microfluidic-basedbiosensor.....................................................................319

17.2.9Mass-spectroscopy-basedbiosensor..........................................................319

17.3 Potentialpoint-of-carminiaturizedbiosensor.......................................................320 17.4 Conclusion..............................................................................................................335

CHAPTER18Microfluidicdeviceswithintegratedbiosensorsfor

ArushiGupta,MayankGarg,SumanSingh,AkashDeepand AmitL.Sharma

18.1 Introductiontocoronavirus....................................................................................341

18.2 AvailabledetectionmethodsforSARS-CoV-2virus...........................................342 18.3 Microfluidic-basedbiosensorsystem.....................................................................344

CHAPTER19Approachesforfabricationofpoint-of-carebiosensorsforviral

19.7 Fabricationofmolecularlyimprintedpolymer-basedbiosensor...........................361

19.8 Fabricationofmagneticbiosensor.........................................................................363

19.9 Fabricationofthree-dimensionalprintingbiosensor.............................................366

CHAPTER20Currentlyavailablebiosensor-basedapproachesforsevere acuterespiratorysyndrome-coronavirus2detection ..................... 373 ArpanaParihar,NidhiPuranik,DipeshSinghParihar,PushpeshRanjan andRajuKhan

20.1 Introduction............................................................................................................373

20.2 Diagnosticapproachesforviraldiseases...............................................................374

20.3 Biosensorsinthedetectionofrespiratoryviruses.................................................377 20.3.1Electrochemicalbiosensor.........................................................................377 20.3.2Opticalbiosensor........................................................................................379 20.3.3Piezoelectricbiosensor...............................................................................380 20.3.4Thermalbiosensors....................................................................................380

20.4 Presentdiagnosticmethodsforsevereacuterespiratory syndrome-coronavirus2detection.........................................................................380

20.5

CHAPTER21Biosensors-basedapproachesforotherviralinfection

SoumajitMukherjee,PetraStrakova,LukasRichtera,VojtechAdam andAmirmansoorAshrafi

21.1 Introduction............................................................................................................391

21.3 Importanceofbiosensorinthediagnostics...........................................................394

Detectionofmammalianvirusesbyabiosensor...................................................395

21.5 Importanceandsignificanceofbiologicalanalytes..............................................401

21.6 Futurescopes..........................................................................................................401

CHAPTER22Scalingupofbiosensorsforclinicalapplicationsand commercialization ............................................................................

Ye¸serenSaylan,SemraAkgonullu,NilayBereli,HandanYavuzand AdilDenizli

22.1

22.2

CHAPTER23Futureaspectsofbiosensor-baseddevicesindisease

23.1

Listofcontributors

VojtechAdam

DepartmentofChemistryandBiochemistry,MendelUniversityinBrno,Brno,CzechRepublic; CentralEuropeanInstituteofTechnology,BrnoUniversityofTechnology,Brno,CzechRepublic

SemraAkgo ¨ nu ¨ llu ¨

DepartmentofChemistry,HacettepeUniversity,Ankara,Turkey

P.Aparna

DepartmentofMedicine,AllIndiaInstituteofMedicalSciences(AIIMS),Bhopal,India

NehaArya

TranslationalMedicineCentre,AllIndiaInstituteofMedicalSciences,Bhopal,India

AmirmansoorAshrafi

DepartmentofChemistryandBiochemistry,MendelUniversityinBrno,Brno,CzechRepublic; CentralEuropeanInstituteofTechnology,BrnoUniversityofTechnology,Brno,CzechRepublic

OnkarAwadhiya

DepartmentofGeneralMedicine,AllIndiaInstituteofMedicalSciences(AIIMS),Bhopal,India

GautamBacher

DepartmentofElectricalandElectronicsEngineering,BITSPilaniKKBirlaGoaCampus,Goa, India

NilayBereli

DepartmentofChemistry,HacettepeUniversity,Ankara,Turkey

SunilBhand

BiosensorLab,DepartmentofChemistry,BITSPilaniKKBirlaGoaCampus,Goa,India

DebasisBiswas

RegionalVirologyLaboratory,AllIndiaInstituteofMedicalSciences(AIIMS),Bhopal,India; DepartmentofMicrobiology,AllIndiaInstituteofMedicalSciences(AIIMS),Bhopal,India

ThomasBriese

CenterforInfectionandImmunity,ColumbiaUniversity,NewYork,NY,UnitedStates

PriyaChauhan

SchoolofStudiesinEnvironmentalChemistry,JiwajiUniversity,Gwalior,India

C.Chikkaputtaiah

BiotechnologyGroup,BiologicalSciencesandTechnologyDivision,CSIR-NorthEastInstituteof ScienceandTechnology,Jorhat,India;AcademyofScientificandInnovativeResearch, Headquarters,CSIRHRDCCampus,Ghaziabad,India

RashmiChowdhary

DepartmentofBiochemistry,AllIndiaInstituteofMedicalSciences(AIIMS),Bhopal,India

VishalDas

BiotechnologyGroup,BiologicalSciencesandTechnologyDivision,CSIR-NorthEastInstituteof ScienceandTechnology,Jorhat,India;AcademyofScientificandInnovativeResearch, Headquarters,CSIRHRDCCampus,Ghaziabad,India;SchoolofHealthSciences,Department ofMedicalLaboratoryTechniques,TheAssamKazirangaUniversity,Koraikhowa,Jorhat,India

AkashDeep

CSIR-CentralScientificInstrumentsOrganisation,Chandigarh,India;AcademyofScientificand InnovativeResearch(AcSIR),Ghaziabad,India

H.P.DekaBoruah

BiotechnologyGroup,BiologicalSciencesandTechnologyDivision,CSIR-NorthEastInstituteof ScienceandTechnology,Jorhat,India;AcademyofScientificandInnovativeResearch, Headquarters,CSIRHRDCCampus,Ghaziabad,India;GovernmentModelCollege,Kaziranga, Golaghat,India

AdilDenizli

DepartmentofChemistry,HacettepeUniversity,Ankara,Turkey

ShreyasDeshpande

DepartmentofElectricalandElectronicsEngineering,BITSPilaniKKBirlaGoaCampus,Goa, India

ShimaaEissa

DepartmentofChemistry,AlfaisalUniversity,Riyadh,SaudiArabia

SonuGandhi

DBT-NationalInstituteofAnimalBiotechnology(NIAB),Hyderabad,India

MayankGarg

CSIR-CentralScientificInstrumentsOrganisation,Chandigarh,India;AcademyofScientificand InnovativeResearch(AcSIR),Ghaziabad,India

AmritaGhosh

DepartmentofChemistry,NationalInstituteofTechnology(NIT)Kurukshetra,Kurukshetra,India

K.YugenderGoud

DepartmentofNanoEngineering,UniversityofCaliforniaSanDiego,LaJolla,CA,UnitedStates

VinodSinghGour

AmityInstituteofBiotechnology,AmityUniversityRajasthan,Jaipur,India

ArushiGupta

CSIR-CentralScientificInstrumentsOrganisation,Chandigarh,India;AcademyofScientificand InnovativeResearch(AcSIR),Ghaziabad,India

DivyaGupta

DepartmentofBiochemistry,AllIndiaInstituteofMedicalSciences(AIIMS),Bhopal,India

AmilanD.Jose

DepartmentofChemistry,NationalInstituteofTechnology(NIT)Kurukshetra,Kurukshetra,India

JoshyJoseph

PhotosciencesandPhotonicsSection,CSIR-NationalInstituteforInterdisciplinaryScienceand Technology,Thiruvananthapuram,India;AcademyofScientificandInnovativeResearch (AcSIR),Ghaziabad,India

RajnishJoshi

DepartmentofMedicine,AllIndiaInstituteofMedicalSciences(AIIMS),Bhopal,India

RajuKhan

CSIR-AdvancedMaterialsandProcessesResearchInstitute(AMPRI),Bhopal,India;Academy ofScientificandInnovativeResearch(AcSIR),CSIR-AMPRI,Bhopal,India

AshokKumar

DepartmentofBiochemistry,AllIndiaInstituteofMedicalSciences(AIIMS),Bhopal,India

DeepakKumar

DepartmentofBotany,CenterofAdvancedStudyinBotany,InstituteofScience,Banaras HinduUniversity,Varanasi,India

SubhasisMahari

DBT-NationalInstituteofAnimalBiotechnology(NIAB),Hyderabad,India

H.S.Mann

StateVirologyLaboratory,DepartmentofMicrobiology,GandhiMedicalCollege,Bhopal,India

AdarshMeher

DepartmentofMicrobiology,AllIndiaInstituteofMedicalSciences(AIIMS),Bhopal,India

RupeshK.Mishra

AmityInstituteofBiotechnology,AmityUniversityRajasthan,Jaipur,India;SchoolofMaterials Engineering,PurdueUniversity,WestLafayette,IN,UnitedStates

AtripanMukherjee

DepartmentofChemistryandBiochemistry,MendelUniversityinBrno,Brno,CzechRepublic; CentralEuropeanInstituteofTechnology,BrnoUniversityofTechnology,Brno,CzechRepublic

SoumajitMukherjee

DepartmentofChemistryandBiochemistry,MendelUniversityinBrno,Brno,CzechRepublic

DivyaNamdeo

RegionalVirologyLaboratory,AllIndiaInstituteofMedicalSciences(AIIMS),Bhopal,India

RogerNarayan

DepartmentofBiomedicalEngineering,NorthCarolinaStateUniversity,Raleigh,NC,UnitedStates

VanyaNayak

DepartmentofBiotechnology,IndiraGandhiNationalTribalUniversity,Amarkantak,India

RajeevNema

DepartmentofBiochemistry,AllIndiaInstituteofMedicalSciences(AIIMS),Bhopal,India

RaviRanjanKumarNiraj

AmityInstituteofBiotechnology,AmityUniversityRajasthan,Jaipur,India

NavinPai

DepartmentofNanoEngineering,UniversityofCaliforniaSanDiego,LaJolla,CA,UnitedStates

MintuPal

BiotechnologyGroup,BiologicalSciencesandTechnologyDivision,CSIR-NorthEastInstituteof ScienceandTechnology,Jorhat,India;AcademyofScientificandInnovativeResearch, Headquarters,CSIRHRDCCampus,Ghaziabad,India;SchoolofHealthSciences,Universityof PetroleumandEnergyStudies(UPES),EnergyAcres,Dehradun,India

SmritiPanda

DepartmentofMedicine,AllIndiaInstituteofMedicalSciences(AIIMS),Bhopal,India

AnnuPandey

DepartmentofChemistry,ChandigarhUniversity,Mohali,India

ArpanaParihar

CSIR-AdvancedMaterialsandProcessesResearchInstitute(AMPRI),Bhopal,India

DipeshSinghParihar

EngineeringCollegeTuwa,Godhra,India

GaurangPatel

AmityInstituteofBiotechnology,AmityUniversityRajasthan,Jaipur,India

PriyankaPulugu

DepartmentofMedicalDevices,NationalInstituteofPharmaceuticalEducationandResearch, Ahmedabad,India

NidhiPuranik

CSIR-AdvancedMaterialsandProcessesResearchInstitute(AMPRI),Bhopal,India

RahimRahimi

SchoolofMaterialsEngineering,PurdueUniversity,WestLafayette,IN,UnitedStates;Birck NanotechnologyCenter,PurdueUniversity,WestLafayette,IN,UnitedStates;Schoolof ElectricalandComputerEngineering,PurdueUniversity,WestLafayette,IN,UnitedStates

BinduRameshan

PhotosciencesandPhotonicsSection,CSIR-NationalInstituteforInterdisciplinaryScienceand Technology,Thiruvananthapuram,India;AcademyofScientificandInnovativeResearch (AcSIR),Ghaziabad,India

PushpeshRanjan

CSIR-AdvancedMaterialsandProcessesResearchInstitute(AMPRI),Bhopal,India;Academy ofScientificandInnovativeResearch(AcSIR),CSIR-AMPRI,Bhopal,India

LukasRichtera

DepartmentofChemistryandBiochemistry,MendelUniversityinBrno,Brno,CzechRepublic

AkankshaRoberts

DBT-NationalInstituteofAnimalBiotechnology(NIAB),Hyderabad,India

Mohd.AbubakarSadique

CSIR-AdvancedMaterialsandProcessesResearchInstitute(AMPRI),Bhopal,India

SaurabhSaigal

DepartmentofAnesthesiology,AllIndiaInstituteofMedicalSciences(AIIMS),Bhopal,India

Yes¸erenSaylan

DepartmentofChemistry,HacettepeUniversity,Ankara,Turkey

AmitL.Sharma

CSIR-CentralScientificInstrumentsOrganisation,Chandigarh,India;AcademyofScientificand InnovativeResearch(AcSIR),Ghaziabad,India

VinaySharma

AmityInstituteofBiotechnology,AmityUniversityRajasthan,Jaipur,India

AnirudhK.Singh

DepartmentofMicrobiology,AllIndiaInstituteofMedicalSciences(AIIMS),Bhopal,India

HimadriSingh

DepartmentofBiochemistry,AllIndiaInstituteofMedicalSciences(AIIMS),Bhopal,India

KshitijR.B.Singh

DepartmentofChemistry,Govt.V.Y.T.PGAutonomousCollege,Durg,India

RavindraPratapSingh

DepartmentofBiotechnology,IndiraGandhiNationalTribalUniversity,Amarkantak,India

SumanSingh

CSIR-CentralScientificInstrumentsOrganisation,Chandigarh,India;AcademyofScientificand InnovativeResearch(AcSIR),Ghaziabad,India

AyushiSinghal

AcademyofScientificandInnovativeResearch(AcSIR),Ghaziabad,India;IndustrialWaste Utilization,NanoandBiomaterials,CSIR-AdvancedMaterialsandProcessesResearchInstitute (AMPRI),HoshangabadRoad,Bhopal,India

LiaStanciu

SchoolofMaterialsEngineering,PurdueUniversity,WestLafayette,IN,UnitedStates

PetraStrakova

DepartmentofInfectiousDiseasesandPreventiveMedicine,VeterinaryResearchInstitute, Brno,CzechRepublic

M.K.Verma

DepartmentofBasicSciences,AmericanUniversitySchoolofMedicine,Aruba,Netherlands

Y.K.Verma

DepartmentofLifeScience,MandasaurUniversity,Mandasaur,India

AkankshaWakhare

DepartmentofMedicalDevices,NationalInstituteofPharmaceuticalEducationandResearch, Ahmedabad,India

AshviniKumarYadav

RegionalVirologyLaboratory,AllIndiaInstituteofMedicalSciences(AIIMS),Bhopal,India

ShaluYadav

CSIR-AdvancedMaterialsandProcessesResearchInstitute(AMPRI),Bhopal,India;Academy ofScientificandInnovativeResearch(AcSIR),CSIR-AMPRI,Bhopal,India

HandanYavuz

DepartmentofChemistry,HacettepeUniversity,Ankara,Turkey

TabassumZafar

DepartmentofBioscience,BarkatullahUniversity,Bhopal,India

AminZareei

BirckNanotechnologyCenter,PurdueUniversity,WestLafayette,IN,UnitedStates;Schoolof MaterialsEngineering,PurdueUniversity,WestLafayette,IN,UnitedStates

Preface

Coronavirusesareagroupofvirusesandthesourceofseveralrecentoutbreaks,includingsevere acuterespiratorysyndrome(SARS)in2003,MiddleEastrespiratorysyndrome(MERS)in2012, andmostrecentlytheoutbreakofsevereacuterespiratorysyndrome-coronavirus2(SARS-CoV-2) [coronavirusdisease2019(COVID-19)].Commonly,coronaviruscaninfectbothanimalsand humanbeings,andcancausearangeofrespiratoryillnesses,butinfectionofSARS-CoV-2remains asymptomaticin25%population,andthusinfectedpeopleremainindistinguishablefromhealthy onesandbecomeaseriousthreatastheycanspreadinfectionunknowinglyamongalargechunkof populations.Inpastdecades,threehighlypathogenichumancoronavirusesincludingSARS-CoV, MiddleEastrespiratorysyndrome-coronavirus(MERS-CoV),andSARS-CoV-2haveemergedand triggeredglobalpandemicsthatresultedinhighmorbidityandmortalityglobally.SARS-associated coronavirus,SARS-CoVwasthefirstoutbreakinChina,2002,andspreadswiftlytoover30countries,resultinginmorethan8000casesofSARS-CoV.

TheoutbreakofzoonoticcoronavirusinSaudiArabiain2012knownasMERS-CoVtransferred tohumansfromdromedarycamels.Over27countrieshadreportedcasesofMERS-CoV,leading to858totaldemisesworldwide.InDecember2019,thefirstcaseSARS-CoV-2havingpneumonialikesymptomswasidentifiedinChina.Sincethen,theCOVID-19epidemichasrapidlyspread throughouttheworldandhasundergoneserioushealthconcernsandsocioeconomicburdens.The WHOannouncedCOVID-19asapandemiconMarch11,2020.Globally,asofJanuary16,2021, therehavebeenover92millionconfirmedcasesofCOVID-19ofwhichapproximately1.9million demiseshavebeenreportedandthenumberskeepgrowing.AspertheMinistryofHealthand FamilyWelfaredata,thetotalnumberofactivecoronaviruscasesinIndiastandsatapproximately 10,000,andclaimed . 350deaths,and1193patientshavebeencuredanddischargedasofApril 14,2020.

Earlyscreeningofviralinfectionamongthepopulationhasthepotentialtocombatthespread ofinfection.However,currentlyusedtechnologiesforthediagnosisofinfectionsuchasELISA, PCR,andRT-PCRaresensitiveandgivepromisingresults,buttheyaretime-consuming,require expertanalysis,andarecostly.Thusthedevelopmentofarapid,cheap,andreliablepoint-of-care (POC)testforthedetectionofSARS-CoV-2infectionistheneedofthehour.Advancedbiosensor diagnosticsoffershugepotentialforearlydiagnosisofaspecificdiseasewhichhelpstoenhance thesurvivalrateagainstinfectiousdiseases.Biosensorsofferseveraladvantagesovercurrently availablediagnostictechnologysuchastheyprovidefast,sensitive,portable,easytouse,costeffective,andreliableresultsforaccuratediagnosisofinfectionataveryearlystageevenbefore thesymptomsarise(asymptomaticinfection).Biosensorsconsistoftwoimportantcomponents:a biorecognitionelement(antibody,enzyme,aptamer)andtransducerspart(electrochemical,piezoelectric,optical,calorimetric,magnetic,fluorescence).Thepresentbookdiscussedandcompiled informationaboutthecurrentlyavailablebiosensor-baseddiagnosticapproachesfortheearlydetectionofviralinfection.Thisbookthrowslightontherecentandnovelbiosensor-basedapproaches, whichcanbeexploitedtodevelopaquantitativerapidlab-on-a-chipPOCassayforearlydiagnosis ofvarioustypesofviralinfection.Thebookspecificallyhighlightedthefabricationprocessof high-throughputbiosensor-basedtechnologiesforPOCdiagnosticsandprognosticassessment.This bookwouldprovideaplatformforresearchersandpharmaceuticalcompaniestodesignand

developpromisingbiosensorsforearlyinfectiondiagnosisandsimultaneouslyprovidethem advanced,cost-effectivehigh-throughputapproachesforPOCdiagnosticswhichcanbemultiplexed.Inthisbookweincludedchaptersthatemphasizeaboutvarioustypesofvirusesandbiomarkersalongwithvarioustypesofbiosensorsforbiomarkersbasedontheirbiorecognition elementandtransducercomponent,whicharecurrentlybeingusedorunderclinicaltrialforbiomedicalapplications.Furthermore,theadvantages,challenges,andfutureopportunitiesforapplicationsofadvancedbiosensorsinviralparticledetectionarecompiledherein.

Thesuccessfulcompilationofthisbookisexpectedtoprovideaplatformforthedevelopment ofrapidandcost-effectiveadvancedbiosensors-baseddevicesforthedetectionofSARS-CoV-2 infectionforthebenefitofsociety.Furthermore,thisbookwouldenablethereaderswiththeuseof therightapproach,rightmaterials,rightprocessingmethods,anddevelopmentofstructure propertyrelationshipintermsofdevelopmentofdiagnosticdevices.Whilealotofresearchisstill requiredtoestablishthetrueextentandnatureofthisoutbreak,itisclearthatthespreadingofthe virusisaglobalconcern.

Thebookcomprises23chapters.Chapter1dealswiththeemergenceofthecoronavirusepidemicandpandemic.Italsocoverssomeimportantaspectsofthevirusanditspathophysiology. Chapters2and3,respectively,discussthenovelcoronavirus(SARS-CoV-2)pandemicandglobal publichealthresponsealongwithlessonslearnedfromcoronavirus(SARS-CoV,MERS-CoV,and SARS-CoV-2)andthesocioeconomicimpactofthepandemic.Chapter4describestheprofiling andpathogenesisofSARS-CoV-2.Chapters5and6attempttocoverdetailedinformationabout thecurrentlyavailablediagnostictechniquesandchallengesinthedevelopmentofdiagnostic approachesforSARS-CoV-2.Chapters7and8presentinformationaboutbiomarkers(genomicand proteomic)andriskfactorsassociatedwithvirusinfectionwhichwouldbehelpfulforthedevelopmentofnovelsensors.Chapters9 11dealwiththedevelopmentofelectrochemicalandoptical biosensorsforthedetectionofvirusinfection.Chapters12and13describetheroleofdifferent nanomaterialsincludingmagneticnanoparticlesforthedevelopmentofbiosensors.Chapters14 19 presenttheinformationaboutmultiplexed,acoustic/electrical,fluorescence,miniaturized,microfluidicdevicesfordetectionofvirusinfection.Chapters20and21dealwithvariousapproachesfor thefabricationofPOCTbiosensorsalongwithcurrentlyavailablebiosensorsfordetectionof SARS-CoV-2andotherviruses.Chapter22specificallydescribesvarioustechniquesforscalingup biosensors.Chapter23presentsacriticaloverviewofthefutureprospectsandthecommercialviabilityofbiosensorsforbiomedicaltechnology.Therequiredreferencesarecitedineachchapterfor furtherstudyontherespectivetopic.

Acknowledgments

Alltheeditorsaresincerelythankfultoeverycontributorofthechapters.Theirsincereefforts,hard work,analyticalapproacharehighlyacknowledged.Atthesametime,editorswouldliketo acknowledgepublishersandassociatedteamsforcontinuoussupport,guidance,andmotivation whichconstantlypushthemforwardtocompletethisbook.ThevaluableadviceandguidanceprovidedbyDirector,CSIR-AMPRI,Bhopal,MP,India,aredulyacknowledged.Dr.RajuKhan expresseshisspecialthankstohisparents,wife,daughter,andsonfortheireverlastinglove,enthusiasmforscience,andencouragementtopursueeverytasksuccessfully.Thefinancialsupportfrom SERB(IPA/2020/000130)foraprojectentitled“DevelopmentofRapidElectrochemicalbased DiagnosticsforDetectionofSARS-CoV-2Infection”isalsoacknowledgedbyDr.RajuKhanand Dr.AshokKumar.Dr.ArpanaPariharisgratefultoDSTforprovidingfinancialassistanceunder DST-WoSBscheme.Furthermore,theeditorsaresincerelythankfultoallwhohavedirectlyor indirectlyrenderedvaluableinputtothisbook.

Theemergenceofsevereacute respiratorysyndrome-coronavirus2 epidemicandpandemic

TabassumZafar

DepartmentofBioscience,BarkatullahUniversity,Bhopal,India

1.1 Introduction

Inthehistoryoftravelandtourism,amicroscopiccreaturewroteadarknote,whichinterruptedthe fastpaceofglobalization.InDecember2019,intheseafoodmarketofWuhancityofChina,a severeviralpneumonia-likeinfectionwasinitiated,andwhichwasnewtotheworldandresulted intheemergenceofaglobalhealthemergency.Thousandsofpassengerstraveledthroughthecity withoutknowingthatonetravelcanchangenotonlytheirlivesbutthefutureoftheworld.When WHOdeclaredthesevereacuterespiratorysyndrome-coronavirus2(SARS-CoV-2)outbreakasa globalemergency,stillnoonethoughtoftheconversionoftheepidemicintotheworstpandemic oftheongoingdecade(Cucinotta&Vanelli,2020).Initially,thespreadofSARS-CoV-2infection overawideareawithalotofpatientsatthesametimedeclareditasaglobalepidemic,butthe rapidescalationoftheinfectionatmorecomprehensivegeographicallocationswithasignificant portionoftheinfectedpopulationsoonturnedtheepidemicintothepandemic.Theimportedcases soonspreadtotheirnativeplacesandturnthediseasepandemic.Whilemanycountriesareimposingpartialorcompletelockdownforthesafetyoftravelersandcivilians,thevacanthuman-made spacesandtouristarchitecturesareaskingthatwherethelacunaewere,whichhasputtheglobein suchadevastatingphase(Wuetal.,2020).TheemergenceofSARS-CoV-2createdacolossal healthcrisisfortheentireworld.Fromaprovincialhealthconcerntoaglobalmeltdown,the impactofSARS-CoV-2hasundeniablyimpactedtheworldmedically,socially,financially,and psychologically(Alietal.,2020;Pretietal.,2020).ThefootprintsofSARS-CoV-2areimpactfully imprintedonthedecadethatwillrequirealotoftimeforglobalrecovery.

1.2 Severeacuterespiratorysyndrome-coronavirus2:thememberof

thecoronavirusfamily

SARS-CoV-2isthepathogenofzoonoticoriginthatbelongstothefamily“Coronaviridae,”order “Nidovirales”andrealm“Riboviria.”coronavirusisnotanewentityasfourcategoriesoftheexistingcoronavirusesarealreadyknowntotheworld.Thealpha,beta,delta,andgammacoronaviruses

aretheclassesamongwhichtwocategories,alphaandbetacoronaviruses,havethepotentialto infecthumanbeings.Themutationalchangesintheseunharmfulvirusesmakethemcapableof beingathreattohumanhealth.Todate,sevenhumancoronaviruses(HCoVs)areknown,namedas severeacuterespiratorysyndrome(SARS),MiddleEastrespiratorysyndrome(MERS),SARSCoV-2,HCoV-229E,HCoV-0C43,HCoV-NL63,andHCoV-HKU1(Alsaadetal.,2018;Anderson etal.,2004;Chanetal.,2014;Lietal.,2005;Sextonetal.,2016).SARS-CoV-2wasinitially termedas“Wuhanvirus”or“Chinavirus”butlater,onFebruary11,2020,theWHOannounced thatthenameforthediseasewouldbeCOVID-19.Inthename,COreferstothevirusfamily “Corona,”VIstandsfor“Virus,”Dfor“disease,”and19referstotheyearoftheoutbreak“2019.” Lateron,basedongeneticsimilaritywiththeSARSvirusthe“TheInternationalCommitteeon TaxonomyofViruses”namedit“severeacuterespiratorysyndrome-coronavirus2,”orSARSCoV-2.

1.2.1 SARS-CoV-2inconnectionwithsevereacuterespiratorysyndromecoronavirusandMiddleEastrespiratorysyndrome-coronavirus

BeforetheeruptionofthedeadlySARS-CoV-2epidemic,varioussimilaroutbreakshadhappened inthepast.Thesevirusesinfectedlivesatalargescale,withalittlelessglobalexpansion(Azhar etal.,2019;BaAbduallah&Hemida,2020;Yanetal.,2020).SARS-CoVandalsotheMERSCoVoutbreaksthathappenedinChinaandtheKingdomofSaudiArabiahaveapowerfulcorrelationwithSARS-CoV-2intermsofsimilarityofbatoriginorordinationsimilaritycompared totheotherhumanepidemicvirus(Table1.1).Severalmembersofthecoronaviruses(alpha-coronaviruses:HCoV-229EandHCoV-NL63;beta-coronaviruses;HCoV-OC43andHCoV-HKU1) presentself-limitingdelicatevirulenceentities,buttheseverityoftheSARS-CoV-2virusirruption isincreasedbecauseoftheself-modifyingnatureofthestrain.Therespiratorydisordercausedby SARS-CoV-2featuresapotentialsimilaritytoSARS-CoVandMERS-CoVincomposition, genomesequence,immunologicalresponseidentification,andothersymptoms(Guetal.,2005; Memishetal.,2020).SARS-CoV-2preferspyrimidine-richcodonstopurines(Kandeeletal., 2020).Attheearlystageoftheepidemic,thesimilaritieswiththepreexistentvirusesfacilitatethe investigationsrelatedtodrugtargetingandimmunogenpreparationagainstSARS-CoV-2infection (Hui&Zumla2019).SARSepidemicbeganinGuangdongProvince,China,inNovember2002. SeveralobservationssupportedthehypothesisofawildanimaloriginforSARS.OnMarch12, 2003,theWHOissuedaglobalalertaboutSARScasesinGuangdongProvince,whichsubsequentlyspreadrapidlyworldwide(Leungetal.,2004).SeveralstudiessuggestedthattheSARS probablyoriginatedinthehorseshoebats,andlaterpassedthroughpalmcivetsbeforereaching humans.Similarly,MERS-CoVwasfoundtopossesssimilaritywithtwobatcoronaviruses,HKU4 andHKU5withconfirmedinfectionincamelsbetheintermediatehostandhumansasapossible host(Zhuetal.,2020).InDecember2019,SARS-CoV-2infectionoriginatedinanexceedingly similarapproachfromafoodmarketinanurbancenter,HubeiProvince,China,thatatfirstshowingthesymptomsofrespiratorydisorder.Undoubtfully,SARS-CoV-2isanextremelyinfectious viruscomparedtotheSARS-CoVassociatedegreedMERS-CoVbecauseithasalreadykilled millionsofpeopleworldwidewiththeunsurpassedepidemicpotentialinanuncontrolledpattern (Rabaanetal.,2020).

Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.